Medical News

The University of Wisconsin School of Medicine and Public Health is among the first medical centers in the country taking part in a novel clinical trial investigating if a subject’s own stem cells can treat a form of severe coronary artery disease. The trial, just underway at UW Hospital and Clinics, is enrolling subjects in the Autologous Cellular Therapy CD34-Chronic Myocardial Ischemia (ACT34-CMI) Trial. The first patient underwent the procedure March 7. Because the study is randomized and “double-blinded,” however, neither the patient nor the research doctor knows if he received his own stem cells or a placebo substance……..

Original post by Health news from medicineworld.org

The University of Wisconsin School of Medicine and Public Health is among the first medical centers in the country taking part in a novel clinical trial investigating if a subject’s own stem cells can treat a form of severe coronary artery disease. The trial, just underway at UW Hospital and Clinics, is enrolling subjects in the Autologous Cellular Therapy CD34-Chronic Myocardial Ischemia (ACT34-CMI) Trial. The first patient underwent the procedure March 7. Because the study is randomized and “double-blinded,” however, neither the patient nor the research doctor knows if he received his own stem cells or a placebo substance……..

Original post by Health news from medicineworld.org